Northeast Pharmaceutical Group Co., Ltd.

Sembol: 000597.SZ

SHZ

4.66

CNY

Bugünkü piyasa fiyatı

19.6168
F/K Oranı
-0.2211
PEG Oranı
6.66B
MRK Kapağı
0.02%
DIV Verimi

Northeast Pharmaceutical Group Co., Ltd. (000597-SZ) Finansal Tablolar

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Northeast Pharmaceutical Group Co., Ltd. (000597.SZ). Şirketin geliri 3690.249 M ortalamasını gösterir ki bu da 0.094 % gowth'dur. Tüm dönem için ortalama brüt kar 1204.887 M olup 0.121 % dir. Ortalama brüt kar oranı 0.279 %dır. Şirketin geçen yılki performansı için net gelir artışı 0.023 % olup -0.622 % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Northeast Pharmaceutical Group Co., Ltd.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam 0 olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin 0.106 olduğu görülür. Dönen varlıklar alanında, 000597.SZ raporlama para birimi cinsinden 9783.06 değerini gösterir. Bu varlıkların önemli bir kısmı, tam olarak 5651.183, nakit ve kısa vadeli yatırımlarda tutulmaktadır. Bu bölüm, geçen yılın verileriyle yan yana getirildiğinde 0.470% oranında bir değişim göstermektedir. Şirketin uzun vadeli yatırımları, odak noktası olmamakla birlikte, raporlama para biriminde 0 seviyesindedir. Bu, şirketin stratejik değişimlerini yansıtan son raporlama dönemine göre 100.000%'lik bir farka işaret etmektedir. Şirketin borç profili, raporlama para biriminde 352.8 uzun vadeli toplam borcu göstermektedir. Bu rakam, yıldan yıla 2.096%'lik bir değişimi ifade etmektedir. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde 4988.27 olarak değerlenir. Bu açıdan yıldan yıla değişim 0.094%'dir. Şirketin mali tablolarına daha derinlemesine bakıldığında ek ayrıntılar ortaya çıkmaktadır. Net alacaklar 2616.561 değerinde, envanter 1364.09 değerinde ve varsa şerefiye 26.12 değerindedir. Varsa, toplam maddi olmayan duran varlıklar 824.5 ile değerlenir. Hesap borçları ve kısa vadeli borçlar sırasıyla 1398.1 ve 6527.42 şeklindedir. Toplam borç 6911.5, net borç ise 1260.32'dir. Diğer kısa vadeli borçlar 1511.8 tutarındadır ve 9957.79 toplam borçlara eklenir. Son olarak, eğer varsa, anılan hisse senedi 0 ile değerlenir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	20024.02	5651.2	3844.9	2550.4	1481.3	1525.4	1283.6	1709.8	1773.4	1706.5	1766	1539	852.3	798.1	1057	1764	768	319.4	214	374.2	467.6	359.6	336.5	220.8	213.9	226.8	152.4	150.7	236.4	130.2	118.6	28.6
balance-sheet.row.short-term-investments	0	0	0	0	0	0	-1.6	-1.8	-0.9	-1.9	-3.1	-4.2	-5	-5.8	0	-59	0	0	0	3.1	3.3	0	0	0	0	65.5	65.5	65.5	105.5	0	0	3.7
balance-sheet.row.net-receivables	11582.19	2616.6	2840.9	2956.8	2777.5	3015.9	2973.2	2469.6	1774.9	1309.9	1337.5	1092	960	976.1	1159.8	1170.5	1112.6	1306.6	882.5	973.1	850.4	997.9	1170.3	1475.2	95.7	87.7	160.1	58.5	51.2	34.1	58.3	32
balance-sheet.row.inventory	5402.13	1364.1	1220.4	1247.3	1253.2	1283.8	1271.2	1352.9	1092.4	861.5	978.1	1067.9	841.5	875.2	762.6	659.7	673.1	587.1	434.7	387.5	421.8	405.1	398.9	349.7	210.7	212.2	207.9	191.5	315.3	280.3	248.2	198.8
balance-sheet.row.other-current-assets	352.48	151.2	24.3	44.9	41.2	54.3	65.3	38.4	399.1	20.2	55	6.7	0.1	0	-51.3	-49.2	0.1	-221.1	8.6	-144	0.5	0.5	0.8	1	1406.5	1267.8	1252.8	955.9	762	652.4	536.4	544.6
balance-sheet.row.total-current-assets	37360.81	9783.1	7930.5	6799.3	5553.2	5879.4	5593.3	5570.7	5040	3898.1	4136.6	3705.6	2653.9	2649.4	2928.1	3545	2553.9	1991.9	1539.8	1590.7	1740.4	1763	1906.5	2046.7	1926.8	1794.4	1773.2	1356.7	1364.9	1096.9	961.5	804
balance-sheet.row.property-plant-equipment-net	18042.19	4511.2	4852.5	5226.4	5488.5	5421.2	4781.8	3792.1	3721.1	3816.5	3412.1	2793.6	2306.2	2117.5	1786.5	1657.7	1143.9	748.2	545	588.6	558.6	588.2	585.3	515.9	524.4	581	577.6	561.5	1230.4	1001.6	538.7	629
balance-sheet.row.goodwill	104.47	26.1	26.1	26.1	26.1	26.1	26.1	36.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	3305.87	824.5	828.6	952	943.6	920.1	854	914.4	868.2	844.2	802.3	790.2	830.3	878.7	856.3	837.8	354.4	233.1	106.7	100.5	112.6	144.2	164.9	165.6	170.4	156.5	159.2	132.3	136	139.4	42.3	37
balance-sheet.row.goodwill-and-intangible-assets	3410.34	850.6	854.7	978.1	969.7	946.2	880.1	951.4	868.2	844.2	802.3	790.2	830.3	878.7	856.3	837.8	354.4	233.1	106.7	100.5	112.6	144.2	164.9	165.6	170.4	156.5	159.2	132.3	136	139.4	42.3	37
balance-sheet.row.long-term-investments	1.41	0	0	2.2	2.4	2.1	3.2	3.4	2.5	3.5	4.7	5.8	6.6	9.4	0	65.4	0	0	0	13.2	16.3	0	0	0	0	10	9.8	-64.9	69.6	0	0	0
balance-sheet.row.tax-assets	486.64	128.1	109.2	102.1	89	90.5	86.8	66.3	51.2	45.3	32.6	41.3	24.5	39	27.3	32	43.5	70	0	0	0	0	0	0	0	-6.9	68.9	65.5	105.5	0	0	0
balance-sheet.row.other-non-current-assets	123.57	0.7	63.4	71.3	62.9	200.5	373.5	209.1	107	85	184.6	218.1	171.9	178.5	7.4	-59	8.2	8.1	16.1	4.8	6.4	26.3	24.4	27.8	47.6	66.4	1.5	114.8	190.7	214.3	55.6	33.5
balance-sheet.row.total-non-current-assets	22064.14	5490.6	5879.8	6380.2	6612.5	6660.5	6125.4	5022.3	4750	4794.5	4436.2	3849	3339.4	3223.1	2677.6	2534	1550.1	1059.4	667.7	707.1	694	758.7	774.5	709.3	742.4	806.9	816.9	809.2	1732.3	1355.3	636.6	699.5
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	59424.95	15273.7	13810.3	13179.5	12165.7	12539.8	11718.7	10593	9790	8692.6	8572.9	7554.6	5993.3	5872.5	5605.7	6078.9	4104	3051.3	2207.5	2297.9	2434.3	2521.7	2681	2756	2669.2	2601.4	2590.1	2165.9	3097.2	2452.2	1598.1	1503.5
balance-sheet.row.account-payables	12329.58	1398.1	4320.5	3695.8	2763.9	2695.7	2522.6	1634.3	1609.9	984.8	856.1	783.2	768	695.9	674.7	680.1	592.5	480.4	356.3	435.8	421.2	521.2	372.8	360.3	273.8	304	356.2	249.2	278	232.3	141	143.3
balance-sheet.row.short-term-debt	17072.17	6527.4	1976.8	3179.8	3309.5	3784.5	3045.6	3583.5	2812.6	3239.7	2992	3106.5	2288.1	2030.3	1067.2	1615.9	1563.4	1371.9	536.8	525.3	623.1	729.3	1044.8	1042.5	1024.8	810.3	675.7	560.8	894.8	733.4	548.8	495.4
balance-sheet.row.tax-payables	300.92	55.6	155.6	65.2	85.7	78.3	63	60.3	45.3	23.9	26.5	31.3	13	-18.4	-89.3	50.6	62.4	35.8	38.7	18.4	42.9	15.2	15.9	28.5	34.2	38.1	34.7	23.5	16.3	17	19.8	22.9
balance-sheet.row.long-term-debt-total	1575.12	352.8	255.9	218	200	150	874.3	235	600	543	100	100	608.6	609.4	1162.8	1011.3	6	55	70	143.7	171	141	45.7	90.8	51.7	265.5	275.6	306.3	663.6	540	178.3	189.2
Deferred Revenue Non Current	641.17	157.1	174.7	194	213.3	223.5	215.6	245.9	249	237	241	211.8	0	301.2	332.5	332.5	59.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	18.94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3236.7	1511.8	1933.1	11	11.9	112.8	1020.3	105.7	91.2	74.4	219.8	81.8	71.3	85.3	76.5	70	72.9	54.3	52.4	59.4	61.4	31.9	55.3	63.1	27.7	0.7	0.5	0.5	2.5	1	0.2	35.1
balance-sheet.row.total-non-current-liabilities	2571.93	389.3	673.9	690.6	727.3	722.8	1474.5	2005.2	2422.5	1660.6	1399.8	1463.9	826.5	1103.1	1606.2	1378.2	86	85.1	91.1	155.7	199.9	147.8	49.6	97.5	83.1	269	268.3	305.7	665.7	543.8	178.3	189.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	114.15	31.3	17.9	18	56.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	39075.25	9957.8	9097.1	8889.2	8043.5	8622	8125.9	8045	7356	6291.6	5811.7	5955.5	4243	4129.6	3540.2	4025.3	2529.4	2162.1	1280	1397.8	1550.3	1651.5	1807.7	1872.6	1763.7	1731.6	1591	1230.5	2102.6	1677.1	1110.9	1052.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	5726.84	1429.1	1434.3	1347.9	1350.7	904.7	569.6	474.7	474.7	474.7	474.7	333.8	333.8	333.8	333.8	333.8	333.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	303.8	253.2	194.8	194.8	149.8	149.8	149.8
balance-sheet.row.retained-earnings	3762.51	1013.4	805.2	496.1	416.1	403.8	253.8	79.8	-39.1	-62.9	321.4	234.3	401.3	393.6	783.5	770.2	369.2	69.1	1.5	-14.7	-13.8	-8	-16.3	-4.2	11.1	-117.5	51.1	0	18	89.2	49.2	44
balance-sheet.row.accumulated-other-comprehensive-income-loss	6516.79	462.4	296.9	425.2	446.9	406.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3512.39	2083.4	2022.9	1874.6	1766.9	2096	2647.3	1879.1	1879	1877.5	1868.2	935.3	930.1	929.8	906	915.2	868.6	514.4	622.2	611	594	574.5	585.7	584.2	590.5	683.3	694.6	740.6	781.9	536.1	288.2	257.3
balance-sheet.row.total-stockholders-equity	19518.53	4988.3	4559.3	4143.7	3980.6	3810.8	3470.8	2433.6	2314.5	2289.2	2664.3	1503.4	1665.2	1657.1	2023.3	2019.2	1571.5	887.4	927.5	900.1	884	870.3	873.3	883.8	905.4	869.5	998.9	935.4	994.6	775.1	487.1	451.1
balance-sheet.row.total-liabilities-and-stockholders-equity	59424.95	15273.7	13810.3	13179.5	12165.7	12539.8	11718.7	10593	9790	8692.6	8572.9	7554.6	5993.3	5872.5	5605.7	6078.9	4104	3051.3	2207.5	2297.9	2434.3	2521.7	2681	2756.5	2669.2	2601.4	2590.1	2165.9	3097.2	2452.2	1598.1	1503.5
balance-sheet.row.minority-interest	674.05	170.5	153.9	146.5	141.6	107	122.1	114.4	119.5	111.8	96.9	95.6	85.1	85.7	42.1	34.4	3	1.8	0	0	0	0	0	0.1	0.2	0.2	0.2	0	0	0	0	0
balance-sheet.row.total-equity	20192.58	5158.7	4713.3	4290.3	4122.2	3917.8	3592.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	59424.95	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1.41	0	0	2.2	2.4	2.1	1.6	1.6	1.6	1.6	1.6	1.6	1.6	3.7	4.6	6.4	8.2	8.1	15.1	16.3	19.6	21.8	22.4	25	53	75.5	75.3	0.6	175.1	0	0	3.7
balance-sheet.row.total-debt	18700.31	6911.5	2232.7	3397.8	3509.5	3934.5	3045.6	3818.5	3412.6	3782.7	3092	3206.5	2896.7	2639.7	2230	2627.2	1569.4	1426.9	606.8	669	794.1	870.3	1090.4	1133.3	1076.5	1075.9	951.3	867.1	1558.3	1273.5	727.1	684.6
balance-sheet.row.net-debt	-1323.7	1260.3	-1612.2	847.4	2028.3	2409.1	1762	2108.7	1639.2	2076.2	1326	1667.4	2044.4	1841.6	1173	863.1	801.4	1107.5	392.8	297.9	329.8	510.7	753.9	912.5	862.6	914.6	864.4	781.9	1427.4	1143.3	608.5	659.6

Nakit Akış Tablosu

Northeast Pharmaceutical Group Co., Ltd.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek -0.594 şeklinde bir değişim sergilemiştir. Şirket kısa süre önce 0 ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla -0.363 oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden -227964763.000 tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre -0.111 değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan 575.08, 0 ve -1749.6 'i kaydetti. Şirketin finansman faaliyetleri 0.000 net nakit kullanımına yol açmış ve bir önceki yıla göre 0.000 farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için -142.91 ayırmıştır. Aynı zamanda, -1183.06 olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	346.04	358.5	357	95.4	10.8	170.4	201.4	92.1	26.3	-392.2	83.8	-165.2	12.2	-383.2	57.3	476.1	357.9	47	19.6	13.4	8.1	8.7	10.2	10.1	28.8	43.4	68.3
cash-flows.row.depreciation-and-amortization	-4.3	575.1	561.1	550.9	480.8	340.4	323	326.3	317.3	213	171.3	147.7	158.9	217.8	190.2	128	105.3	101.7	80.2	85.6	62.4	66.5	51.1	44.1	36.3	36.2	42.5
cash-flows.row.deferred-income-tax	-354.72	-18.9	-7.2	-13.2	1.3	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	102.23	-1899.7	79.8	-1.2	52.4	156.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	100.67	-647	254	-113.6	-172.6	-582.4	-656.8	-952.2	-125	64.7	-256.8	-375.6	96.5	-200.7	-15.3	-56.7	-43.8	-168.5	-267.7	-54.3	67	97.2	66.8	-50.6	-116.1	-122.8	-167.2
cash-flows.row.account-receivables	149.06	149.1	115	-268.9	249.2	-79.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-150.94	-150.9	-5.6	8.3	-35.4	-105.7	49.3	-232.1	-236.1	96.5	22.4	-200.2	26.1	-143.5	-101.7	15.3	-79.4	-149.4	-45.9	29.3	-42.6	-13.2	-50.5	-130.6	1.5	0.3	-7.6
cash-flows.row.account-payables	0	-747.7	151.8	160.3	-387.8	-396.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	102.54	102.5	-7.2	-13.2	1.3	-0.9	-706.1	-720.2	111	-31.8	-279.2	-175.4	70.3	-57.2	86.4	-72	35.6	-19.1	-221.8	-83.6	109.6	110.5	117.3	80	-117.6	-123.1	-159.6
cash-flows.row.other-non-cash-items	377.38	2218.9	-136.1	228.2	198.2	268.1	417.6	232.6	165.8	214.2	48.7	126.7	-181.5	132.8	23.8	68.5	289.6	218.3	61.9	66.8	73.5	57.6	29.3	75.2	87.1	97.9	48.8
cash-flows.row.net-cash-provided-by-operating-activities	567.29	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-249.37	-235.4	-244.1	-119.8	-400.4	-229.2	-565.7	-414.6	-177	-346	-532.3	-452	-178.9	-421.7	-473.9	-862.8	-359.3	-87.8	-47.8	-103.7	-61.1	-87.5	-38.1	-46.6	-12.2	-9.4	-21.4
cash-flows.row.acquisitions-net	0.42	7.5	3.2	7.8	77.7	-4	0.1	-23.1	186.2	325.3	0	-1	0	54.8	0	10.1	1.5	0	0	127.4	8.3	0	5.8	50.2	12.4	9.4	0.1
cash-flows.row.purchases-of-investments	0	0	0	-500	0	0	0	-16	-1667.9	-325	0	-0.3	0	0.4	0	8.3	3.8	0	0	-0.9	-41.5	0	-0.3	-1.3	-0.5	-16.2	-12.2
cash-flows.row.sales-maturities-of-investments	0	0	0	15.9	0	0	0	399.5	1300.7	2.4	1.3	454.7	1.5	1.4	0	0.3	0.4	0.3	4.6	14.8	0.7	1.4	16.9	5.6	57.4	1.7	61.3
cash-flows.row.other-investing-activites	0.42	0	-15.4	496	0	1.1	2.6	2.6	-177	-40.3	58.1	-452	3	72.4	141.5	324.2	38.3	22.1	3.7	-103.7	14.1	8.4	0	-46.6	-12.2	-9.4	5.3
cash-flows.row.net-cash-used-for-investing-activites	-248.95	-228	-256.3	-100.1	-322.7	-232.1	-563	-51.7	-535	-383.7	-472.9	-450.6	-174.3	-292.5	-332.4	-519.8	-315.3	-65.5	-39.5	-66	-79.5	-77.6	-15.7	-38.6	44.9	-23.9	33.2
cash-flows.row.debt-repayment	-3639	-1749.6	-3355.7	-4061.6	-4091.2	-4217.8	-5427.7	-2919.6	-4217.5	-3674.5	-4058.8	-2648.1	-2200.9	-1153.8	-2055.4	-2314.5	-1873.3	-1324.1	-361.7	-560.7	-651.4	-1322.3	-1056.2	-1192.6	-816.9	-242	-141.3
cash-flows.row.common-stock-issued	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-14.22	-14.2	0	-7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-235.2	-142.9	-109.5	-165.5	-125	-135.6	-166.6	-159.3	-156.4	-184.2	-199.6	-189.9	-175.4	-142	-163.6	-123.1	-129	-67.9	-17.2	-25.9	-54	-66.5	-64.7	-66.6	-62.3	-82.8	-78.3
cash-flows.row.other-financing-activites	943.99	-1183.1	3406.1	4094.7	3856.9	4248.5	5449	3196.7	4465	4029.9	4915.2	4263.5	2462	1588.8	1671	3329.6	1859.6	1359	367.2	454	678.6	1259.4	1094.9	1245.6	853.9	368.4	195.7
cash-flows.row.net-cash-used-provided-by-financing-activities	254.79	381.1	-59	-132.4	-359.3	-104.9	-145.2	117.8	91.1	171.1	656.7	1425.5	85.7	293	-548	892	-142.7	-33	-11.7	-132.6	-26.8	-129.4	-25.9	-13.6	-25.3	43.6	-23.9
cash-flows.row.effect-of-forex-changes-on-cash	10.09	6.3	6.9	-1.7	-1.6	0.6	0.6	-6	2.5	0.6	0	-0.2	0	0	-0.1	0	0	0	0	0	0.2	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	1727.72	1806.3	800.2	512.4	-112.7	16.2	-422.6	-241.1	-56.9	-112.3	230.8	708.3	-2.5	-232.9	-624.6	988.1	251	100.1	-157.1	-87.2	105	23.1	115.7	26.6	55.7	74.4	1.7
cash-flows.row.cash-at-end-of-period	16470	5651.2	2020.8	1220.6	708.3	820.9	804.7	1227.3	1468.4	1525.3	1637.6	1406.8	698.5	701	933.9	1558.5	570.4	319.4	214	371.1	464.3	359.6	336.5	220.8	213.9	161.3	86.9
cash-flows.row.cash-at-beginning-of-period	14742.27	3844.9	1220.6	708.3	820.9	804.7	1227.3	1468.4	1525.3	1637.6	1406.8	698.5	701	933.9	1558.5	570.4	319.4	219.3	371.1	458.3	359.4	336.5	220.8	194.2	158.3	86.9	85.2
cash-flows.row.operating-cash-flow	567.29	586.8	1108.6	746.5	570.9	352.6	285.1	-301.2	384.5	99.7	47	-266.4	86.1	-233.3	256	615.9	709	198.6	-106	111.4	211.1	230.1	157.4	78.8	36.1	54.6	-7.6
cash-flows.row.capital-expenditure	-249.37	-235.4	-244.1	-119.8	-400.4	-229.2	-565.7	-414.6	-177	-346	-532.3	-452	-178.9	-421.7	-473.9	-862.8	-359.3	-87.8	-47.8	-103.7	-61.1	-87.5	-38.1	-46.6	-12.2	-9.4	-21.4
cash-flows.row.free-cash-flow	317.92	351.3	864.4	626.7	170.5	123.4	-280.6	-715.8	207.5	-246.3	-485.3	-718.4	-92.8	-655	-218	-246.9	349.8	110.8	-153.8	7.7	149.9	142.6	119.3	32.3	23.9	45.2	-29

Gelir Tablosu Satırı

Northeast Pharmaceutical Group Co., Ltd.'nın geliri bir önceki döneme göre -0.074% oranında bir değişim gösterdi. Şirketin 000597.SZ brüt kârı 3140.22 olarak raporlanmıştır. Şirketin işletme giderleri 2773.84 olup, geçen yıla göre -6.838% değişim göstermiştir. Amortisman ve itfa giderleri 575.08, yani 0.025% son hesap dönemine göre değişimdir. İşletme giderleri 2773.84 olarak raporlanmıştır ve yıldan yıla -6.838% değişim göstermektedir. Satış ve pazarlama giderleri 0, bir önceki yıla göre 0.000% değişimdir. Son rakamlara göre FAVÖK 0 olup, yıldan yıla -0.003% büyümeyi temsil etmektedir. Faaliyet geliri 366.37 olup, bir önceki yıla göre -0.003% değişim göstermektedir. Net gelirdeki değişim 0.023%'dir. Geçen yılın net geliri 358.46 idi.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	7791.84	8161.4	8808.9	8145.1	7384.4	8220.1	7466.6	5676.4	4814.4	3834.4	4333.3	3870.6	3864.9	3882.8	4828.7	5093.6	4609.8	3706.1	1918.2	1833.1	1619.7	1606.9	1397	1442	1197.6	1011.5	760.6	757.5	1166.1	1049.7	934.6	1001.8
income-statement-row.row.cost-of-revenue	4811.3	5021.2	5377.4	4928.9	4492.7	4638	4377.2	3431.8	3295.1	2817.1	2967.1	2675.8	2908.4	3090.2	3697.8	3535.9	3031.5	2983.7	1497.6	1410.6	1243.7	1227.2	1111.5	1131.8	897.6	734.7	560.4	608.2	1018.2	891.2	716.6	727.1
income-statement-row.row.gross-profit	2980.54	3140.2	3431.5	3216.2	2891.7	3582.1	3089.4	2244.6	1519.3	1017.3	1366.3	1194.8	956.5	792.6	1130.9	1557.7	1578.2	722.4	420.6	422.5	376	379.7	285.5	310.2	300	276.8	200.2	149.2	147.9	158.5	218	274.8
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	98.77	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	167.44	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	1611.42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-110.08	-188.1	498.2	452.3	442	584.9	137.8	-12.4	43.4	26.5	112.6	44.6	377.3	89	98.7	72	5.4	31.5	8.4	-11.4	-4	0.9	-0.7	-4.5	1.9	23.1	15	-72.4	-0.1	12.4	10	4.8
income-statement-row.row.operating-expenses	2472.45	2773.8	2977.5	2859.9	2565.8	3134.2	2617.7	1878.8	1323.7	1214.1	1182	1227.7	1117	1103.2	951.2	905	723.7	452.8	344.6	341.9	301.2	315	212.4	212	214.3	181.1	86	93.1	115.8	93.8	108.3	181.2
income-statement-row.row.cost-and-expenses	7283.75	7795.1	8354.8	7788.8	7058.4	7772.2	6994.9	5310.6	4618.8	4031.3	4149	3903.5	4025.4	4193.4	4649.1	4440.9	3755.2	3436.5	1842.3	1752.5	1544.9	1542.1	1323.9	1343.8	1111.9	915.8	646.4	701.3	1134	985	824.8	908.3
income-statement-row.row.interest-income	167.26	155.1	93.9	55.9	58.4	26.3	31	17.8	28	22.1	26.4	14.4	9.9	12.1	12.5	11.6	5.4	3.5	4.1	4.6	5.5	4.9	2.7	2	9.2	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	76.68	78.4	92.1	120.2	120.9	125.6	154.6	161.7	146.1	153.6	166.1	162.6	141.6	114.4	118.9	97.3	111.1	70.1	39.4	37.9	47.1	64.7	77.3	78.8	66	72.9	70.4	65.5	13.9	26.9	47.3	45.8
income-statement-row.row.selling-and-marketing-expenses	1611.42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	35.92	121.8	158.1	-228.2	-187.2	-265.1	-258	-263.6	-158.2	-210	-78.5	-126.1	203	-70.7	-102.5	-68.3	-354.9	-137.6	-38.8	-39.1	-40.5	-65.7	-75	-76.2	-52.2	-66.9	-45.9	-135.3	-10.3	-8.2	-43.9	-39.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-110.08	-188.1	498.2	452.3	442	584.9	137.8	-12.4	43.4	26.5	112.6	44.6	377.3	89	98.7	72	5.4	31.5	8.4	-11.4	-4	0.9	-0.7	-4.5	1.9	23.1	15	-72.4	-0.1	12.4	10	4.8
income-statement-row.row.total-operating-expenses	35.92	121.8	158.1	-228.2	-187.2	-265.1	-258	-263.6	-158.2	-210	-78.5	-126.1	203	-70.7	-102.5	-68.3	-354.9	-137.6	-38.8	-39.1	-40.5	-65.7	-75	-76.2	-52.2	-66.9	-45.9	-135.3	-10.3	-8.2	-43.9	-39.1
income-statement-row.row.interest-expense	76.68	78.4	92.1	120.2	120.9	125.6	154.6	161.7	146.1	153.6	166.1	162.6	141.6	114.4	118.9	97.3	111.1	70.1	39.4	37.9	47.1	64.7	77.3	78.8	66	72.9	70.4	65.5	13.9	26.9	47.3	45.8
income-statement-row.row.depreciation-and-amortization	354.3	575.1	561.1	550.9	480.8	340.4	323	326.3	317.3	213	171.3	147.7	158.9	217.8	190.2	128	105.3	101.7	80.2	85.6	62.4	66.5	51.1	44.1	36.3	36.2	42.5	43.1	6.5	15.3	37.4	46.1
income-statement-row.row.ebitda-caps	808.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	454.28	366.4	367.4	348.3	279	489.3	76	114.5	1.6	-403.2	7.1	-202.9	-332.4	-469.6	37.9	532.4	495	102	51.7	48.9	30.6	8.4	14.4	25.6	37.7	48.9	77.9	13	25.5	49.4	72.4	47.5
income-statement-row.row.income-before-tax	490.21	488.2	525.4	120.2	91.8	224.2	213.7	102.2	37.4	-406.9	105.7	-159	42.5	-381.2	77.1	584.4	499.7	131.9	48.6	39.5	30.5	4.1	5.9	21.6	36.6	50.4	80.6	-69.2	23.6	59.1	74.1	53.4
income-statement-row.row.income-tax-expense	127.72	112.2	168.4	24.7	81	53.8	12.4	10.1	11.1	-14.7	21.9	6.2	37	0.2	23.3	108.3	141.7	84.9	29	26.1	22.3	8.8	-4.2	11.5	7.8	7	12.4	-53	3.6	12	10.9	9.4
income-statement-row.row.net-income	346.04	358.5	350.3	99	12.3	174	195.2	119	23.8	-384.4	87.1	-167	8.1	-390	50	476.1	357.9	47.5	19.6	13.4	8.1	8.7	10.2	10.1	28.9	43.4	68.2	-69.2	19.9	47.1	63.2	44